Your browser doesn't support javascript.
loading
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design.
Flaherty, Keith T; Gray, Robert; Chen, Alice; Li, Shuli; Patton, David; Hamilton, Stanley R; Williams, Paul M; Mitchell, Edith P; Iafrate, A John; Sklar, Jeffrey; Harris, Lyndsay N; McShane, Lisa M; Rubinstein, Larry V; Sims, David J; Routbort, Mark; Coffey, Brent; Fu, Tony; Zwiebel, James A; Little, Richard F; Marinucci, Donna; Catalano, Robert; Magnan, Rick; Kibbe, Warren; Weil, Carol; Tricoli, James V; Alexander, Brian; Kumar, Shaji; Schwartz, Gary K; Meric-Bernstam, Funda; Lih, Chih-Jian; McCaskill-Stevens, Worta; Caimi, Paolo; Takebe, Naoko; Datta, Vivekananda; Arteaga, Carlos L; Abrams, Jeffrey S; Comis, Robert; O'Dwyer, Peter J; Conley, Barbara A.
Afiliación
  • Flaherty KT; Massachusetts General Hospital, Boston, MA, USA.
  • Gray R; Dana Farber Cancer Institute ECOG-ACRIN Biostatistics Center, Boston, MA, USA.
  • Chen A; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Li S; Dana Farber Cancer Institute ECOG-ACRIN Biostatistics Center, Boston, MA, USA.
  • Patton D; Center for Biomedical Informatics and Information Technology, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Hamilton SR; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA, USA.
  • Iafrate AJ; Massachusetts General Hospital, Harvard University, Boston, MA, USA.
  • Sklar J; Yale University, New Haven, CT, USA.
  • Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.
  • McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Sims DJ; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Routbort M; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Coffey B; Center for Biomedical Informatics and Information Technology, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Fu T; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Zwiebel JA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Marinucci D; ECOG-ACRIN Cancer Research Group, Philadelphia, PA, USA.
  • Catalano R; ECOG-ACRIN Cancer Research Group, Philadelphia, PA, USA.
  • Magnan R; ECOG-ACRIN Cancer Research Group, Boston, MA, USA.
  • Kibbe W; Center for Biomedical Informatics and Information Technology, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Weil C; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Alexander B; Radiation Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
  • Kumar S; Mayo Clinic, Rochester, MN, USA.
  • Schwartz GK; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA.
  • Meric-Bernstam F; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lih CJ; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • McCaskill-Stevens W; Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Caimi P; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
  • Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Datta V; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Arteaga CL; University of Texas Southwestern Simmons Cancer Center, Dallas, TX, USA.
  • Abrams JS; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Comis R; ECOG-ACRIN Cancer Research Group, Philadelphia, PA, USA.
  • O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA, USA.
  • Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.
J Natl Cancer Inst ; 112(10): 1021-1029, 2020 10 01.
Article en En | MEDLINE | ID: mdl-31922567
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Natl Cancer Inst Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Natl Cancer Inst Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos